Medac resubmits treosulfan NDA to FDA, says Medexus Pharmaceuticals

Medexus Pharmaceuticals said that its strategic partner medac has resubmitted the new drug application (NDA) for treosulfan with the US Food and Drug Administration (FDA). ... Read More